AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+36.7%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.37B
AUM Growth
+$4.37B
(+44%)
Cap. Flow
+$620M
Cap. Flow
% of AUM
14.19%
Top 10 Holdings %
Top 10 Hldgs %
43.92%
Holding
157
New
22
Increased
25
Reduced
24
Closed
21
Top Buys
| 1 |
Seer Inc
SEER
|
$328M |
| 2 |
SQZ
SQZ Biotechnologies Company
SQZ
|
$46.6M |
| 3 |
Zillow
Z
|
$45.4M |
| 4 |
IGMS
IGM Biosciences
IGMS
|
$45.1M |
| 5 |
Praxis Precision Medicines
PRAX
|
$41.3M |
Top Sells
| 1 |
BioNTech
BNTX
|
$59.6M |
| 2 |
Alibaba
BABA
|
$52.4M |
| 3 |
Moderna
MRNA
|
$26.1M |
| 4 |
StoneCo
STNE
|
$21.2M |
| 5 |
Scholar Rock
SRRK
|
$19.2M |
Sector Composition
| 1 | Healthcare | 82.45% |
| 2 | Consumer Discretionary | 9.72% |
| 3 | Technology | 2.14% |
| 4 | Communication Services | 1.97% |
| 5 | Real Estate | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Olema Pharmaceuticals
OLMA
$375M
| $12.5M | 0.27% | +260,500 | New | +$12.5M |
|
77
Danaher
DHR
$147B
| $11.1M | 0.24% | 50,000 -25,000 | -33% | -$5.55M |
|
78
Immunic
IMUX
$80.9M
| $10.7M | 0.23% | 700,000 -100,000 | -13% | -$1.53M |
|
|
HOOK
79
DELISTED
HOOKIPA Pharma
HOOK
| $10.5M | 0.23% | 949,616 +350,000 | +58% | +$3.88M |
|
80
Cytokinetics
CYTK
$4.23B
| $10.4M | 0.22% | +500,000 | New | +$10.4M |
|
81
Spero Therapeutics
SPRO
$116M
| $9.7M | 0.21% | 500,000 -100,000 | -17% | -$1.94M |
|
82
Bruker
BRKR
$5.16B
| $9.49M | 0.2% | 175,275 | – | – |
|
|
APTX
83
DELISTED
Aptinyx Inc. Common Stock
APTX
| $8.66M | 0.19% | 2,502,035 +1,000,000 | +67% | +$3.46M |
|
|
EVLO
84
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $8.46M | 0.18% | 700,000 +225,000 | +47% | +$2.72M |
|
85
Applied Therapeutics
APLT
$71M
| $8.36M | 0.18% | 380,000 | – | – |
|
86
Spyre Therapeutics
SYRE
$996M
| $8.22M | 0.18% | 1,045,000 | – | – |
|
|
SYRS
87
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $8.14M | 0.17% | 750,000 +284,500 | +61% | +$3.09M |
|
|
ALPN
88
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $7.47M | 0.16% | 593,030 | – | – |
|
|
ARAV
89
DELISTED
Aravive, Inc. Common Stock
ARAV
| $7.4M | 0.16% | 1,311,291 | – | – |
|
|
MTCR
90
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $7.27M | 0.16% | 924,898 -384,615 | -29% | -$3.02M |
|
91
Celldex Therapeutics
CLDX
$1.47B
| $7.01M | 0.15% | +400,000 | New | +$7.01M |
|
|
YI
92
111 Inc
YI
$55.7M
| $6.95M | 0.15% | 1,000,000 +350,000 | +54% | +$2.43M |
|
93
Leap Therapeutics
LPTX
$12M
| $6.75M | 0.14% | 3,000,000 +174,700 | +6% | +$393K |
|
94
Dyne Therapeutics
DYN
$1.92B
| $6.3M | 0.14% | 300,000 -70,000 | -19% | -$1.47M |
|
95
Ovid Therapeutics
OVID
$91M
| $5.78M | 0.12% | 2,500,000 | – | – |
|
96
Cyclerion Therapeutics
CYCN
$7.91M
| $5.56M | 0.12% | 1,817,584 | – | – |
|
|
97
Moderna
MRNA
$9.37B
| $5.22M | 0.11% | 50,000 -250,000 | -83% | -$26.1M |
|
98
AC Immune
ACIU
$205M
| $5.17M | 0.11% | 1,000,000 | – | – |
|
|
CFRX
99
DELISTED
ContraFect Corporation
CFRX
| $5.05M | 0.11% | +1,000,000 | New | +$5.05M |
|
100
ProQR Therapeutics
PRQR
$237M
| $5.02M | 0.11% | 1,196,218 | – | – |
|